Clinical Trial Update: Effectiveness and Safety of Autologous ADRC for Treatment of Anterior Cruciate Ligament Partial Rupture [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the effectiveness and safety of autologous adipose-derived regenerative cells (ADRC) for treating partial rupture of the a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury

Drugs mentioned

• Autologous ADRC (adipose-derived regenerative cells)

Snippet

Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Conditions: Anterior Cruciate Ligament Partial Rupture | Phase 1, Phase 2 | Status: UNKNOWN